The total magnitude of the T-cell responses induced by mRNA and inactivated SARS-CoV-2 vaccines are comparable; however, the similarity ends here, according to a new study led by Duke-NUS Medical School scientists.
Oct 31, 2022
0
108
In a recent study that represents the largest to date to examine the severity of the SARS-CoV-2 omicron BA.2 subvariant (the strain making a re-emergence this fall), a team led by investigators at Massachusetts General Hospital ...
Oct 26, 2022
0
40
A study at Karolinska Institutet shows that the coronavirus variant BA.2.75.2, an omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments. ...
Oct 14, 2022
0
135
The omicron variant escapes the immune response better than other SARS-CoV-2 variants and their related coronaviruses in humans, bats and pangolins. This finding, published by a research team led by Duke-NUS Medical School ...
Oct 10, 2022
0
55
One year after mass vaccination against COVID-19 was launched, inactivated virus vaccines accounted for half of the doses administered worldwide. Now, a large observational study performed in Brazil and co-led by Fiocruz ...
Oct 6, 2022
1
54
High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many people do not receive detectable antibodies in the airways despite three doses of the SARS-CoV-2 vaccine. These are the ...
Sep 14, 2022
0
149
In a recent study, researchers from Karolinska Institutet and others have characterized the new omicron variant BA.2.75, comparing its ability to evade antibodies against current and previous variants. The study, published ...
Sep 2, 2022
0
56
The majority of people who were likely infected with the omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn't know they had the virus, according to a new study from Cedars-Sinai investigators. The findings ...
Aug 17, 2022
1
100
Researchers at Karolinska Institutet present the results of a refined clinical COVID-19 test, which has been used to track the spread of the omicron variant in real time in the Swedish population. The study, published in ...
Aug 10, 2022
0
59
SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers ...
Aug 1, 2022
0
37
